Clinical Trials Browser

INDUSTRY × Receptors, Chimeric Antigen × Clear all

NCT04650451 2023-04-20

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

Phase 1 Suspended

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms